Financial Daily from THE HINDU group of publications
Sunday, August 15, 2004
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

MARKETS

STOCKS
Cipla slashes anti-AIDS drug prices by 30%
CIPLA has slashed the price on its antiretroviral (ARV) or anti-AIDS drugs range by 25 to 30 per cent in the domestic market. In a letter to doctors, the company said that patients could save more than Rs 360 per month on combination drugs ... More

Stock Quotes
SE Diary
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
Pick a Winner Stock Market Contest

Top Stories
DCA to crack down on errant promoters, directors of NBFCs — Plans 'full-fledged inspection' of books

Containing inflation major challenge: Kalam
`Capacity consolidation in textiles not happening'
Looking back
Aug. 8-Aug. 14
Floating rate funds - spreading on
GTB scrip manipulation — SEBI probe to focus on old suspects
Mutual funds and misclassifications

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line